Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May;14(2):214-27.
doi: 10.2450/2015.0154-15. Epub 2015 Dec 16.

Leucoreduction of blood components: an effective way to increase blood safety?

Maria Bianchi  1   2 , Stefania Vaglio  1   3 , Simonetta Pupella  1 , Giuseppe Marano  1 , Giuseppina Facco  1   4 , Giancarlo M Liumbruno  1 , Giuliano Grazzini  1
Affiliations
Review

Leucoreduction of blood components: an effective way to increase blood safety?

Maria Bianchi et al. Blood Transfus. 2016 May.

Abstract

Over the past 30 years, it has been demonstrated that removal of white blood cells from blood components is effective in preventing some adverse reactions such as febrile non-haemolytic transfusion reactions, immunisation against human leucocyte antigens and human platelet antigens, and transmission of cytomegalovirus. In this review we discuss indications for leucoreduction and classify them into three categories: evidence-based indications for which the clinical efficacy is proven, indications based on the analysis of observational clinical studies with very consistent results and indications for which the clinical efficacy is partial or unproven.

PubMed Disclaimer

Comment in

References

    1. Davenport RD, Snyder EL. Cytokines in transfusion medicine: a primer. Bethesda, MD: American Association of Blood Banks; 1997.
    1. Fergusson D, Khanna MP, Tinmouth A, Hébert PC. Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials. Can J Anaesth. 2004;51:417–24. - PubMed
    1. Blumberg N, Zhao H, Wang H, et al. The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Transfusion. 2007;47:573–81. - PubMed
    1. Blajchman MA. The clinical benefits of the leucoreduction of blood products. J Trauma. 2006;60:S83–90. - PubMed
    1. Bilgin YM, van de Watering LM, Brand A. Clinical effects of leucoreduction of blood transfusions. Neth J Med. 2011;69:441–50. - PubMed